CBE labelling rule does not let manufacturers off the hook, FDA insists
The US Food and Drug Administration (FDA) has defended its proposed rule on product labelling changes made unilaterally through "changes being effected" (CBE) supplements against accusations from Congress, trial lawyers and other quarters that it...